Original Article

Effect of Omega-3 PUFA as Supplementation with Lifestyle Modification on Depression and Anxiety in Overweight Women


Background: Anxiety, stress and depression are still one of the common chronic diseases among Iranian population especially among women in the age of 15-29 years. Associations between depressed mood and lifestyle are well known. The aim of this study was to investigate the effect of omega-3 poly unsaturated fatty acids (PUFA)s supplementation with lifestyle modification on depression and anxiety in overweight women.
Methods: Thirty eight women aged between 20-45 years; body mass index (BMI) equal 25-30; having sedentary lifestyle without any known metabolic, cardiovascular or pulmonary diseases or taking any medication which affect heart rate, blood pressure or exercise capacity were included. Patients randomly divided into two experimental groups. Group 1 received omega-3 capsules plus aerobic exercise and nutrition education classes. Group 2 received placebo capsules plus aerobic exercise and nutrition education classes. All of the subjects in group 1were asked to take one capsule/day, for 8 weeks. The depression level was measured using the Hospital Anxiety and Depression Scale.
Results: There were no significant differences between anxiety and educational level, depression and educational level in overweight women at baseline, 4 and 8 weeks of the study. In addition, no significant correlation was found between changes observed on anxiety and depression extent and different occupations among volunteer women at baseline, 4 and 8 weeks of the study. Omega-3 capsules significantly decreased anxiety and depression compared to control group (P=0.032).
Conclusion: Omega-3 fatty acids supplementation may have beneficial effects onanxiety and depression in overweight women that is not related to lifestylemodification. Further randomized controlled trials with large sample size are needed toconfirm these results

1. Laviano A, Meguid MM. Nutritional issues incancer management. Nutrition 1996; 12: 71-358.
2. Bozzetti F. Nutrition and gastrointestinal cancer.Curr Opin Clin Nutr Metab Care 2001; 4: 541.
3. Fearon KC, Voss AC, Hustead DS .Definition ofcancer cachexia: effect of weight loss, reducedfood intake, and systemic inflammation onfunctional status and prognosis. Am J Clin Nutr2006; 83: 1345-50.
4. DeWys W, Begg C, Lavin P, Band P, Bennett J,Bertino J. Tormey, DC. Prognostic effect ofweight loss prior to chemotherapy in cancerpatients. Eastern Cooperative Oncology Group.Am J Med 1980; 69:491-7.
5. Andreyev H, Norman A, Oates J, Cunningham D.Why do patients with weight loss have a worseoutcome when undergoing chemotherapy forgastrointestinal malignancies? Eur J Cancer 1998;34: 503-9.
6. Rickard KA, Detamore CM, Coates TD, GrosfeldJL, Weetman RM, White NM, et al. Effect ofnutrition staging on treatment delays and outcomein stage IV neuroblastoma. Cancer 1983; 52: 587-98.
7. Ovesen L, Hannibal J, Mortensen EL. The interrelationship of weight loss, dietary intake,and quality of life in ambulatory patients with cancer of the lung, breast, and ovary. Nutr Cancer1993; 19: 159-67.
8. Stephens N, Fearon K. Anorexia, cachexia andnutrition. Medicine 2008; 3: 78-81.
9. MacDonald N. Is there evidence for earlierintervention in cancer-associated weight loss? JSupport Oncol 2003; 1: 279-86.
10. Den Broeder E, Lippens R, Van't Hof M,Tolboom J, Van Staveren W, Hofman Z, et al.Effects of naso-gastric tube feeding on thenutritional status of children with cancer. Eur JClin Nutr 1998; 52: 494-500.Roberge C, Tran M,Massoud C, Poiree B, Duval N, Damecour E, etal. Quality of life and home enteral tube feeding:a French prospective study in patients with headand neck or oesophageal cancer. Br J Cancer2000; 82: 263-9.
11. Van Bokhorst-de Van der Schuer MA,Langendoen SI, Vondeling H, Kuik DJ, Quak JJ,Van Leeuwen PA. Perioperative enteral nutritionand quality of life of severely malnourished headand neck cancer patients: a randomized clinicaltrial. Clin Nutr 2000; 19: 437-44.
12. Jho DH, Cole SM, Lee EM, Espat NJ. Role ofomega-3 fatty acid supplementation ininflammation and malignancy. Integr CancerTher 2004; 3: 98-111.
13. Elia M. Enteral (oral or tube administration)utritional support and eicosapentaenoic acid inpatients with cancer: a systematic review. Int JOncol 2006; 28: 5-23.
14. Hardman WE. (n-3) fatty acids and cancertherapy. J Nutr 2004; 134: 3427S-3430S.
15. Ajani JA, Moiseyenko VM, Tjulandin S, MajlisA, Constenla M, Boni C, et al. Clinical benefitwith docetaxel plus fluorouracil and cisplatincompared with cisplatin and fluorouracil in aphase III trial of advanced gastric orgastroesophageal adenocarcinoma: The V-325Study Group. J Clin Oncol 2007; 25: 3205-9.
16. Naber TH, Schermer T, de Bree A, Nusteling K,Eggink L, Kruimel JW, et al. Prevalence ofmalnutrition in nonsurgical hospitalized patientsand its association with disease complications.Am J Clin Nutr 1997; 66: 1232-9.
17. Baker JP, Detsky AS, Wesson DE, Wolman SL,Stewart S, Whitewell J, et al. Nutritionalassessment. N Engl J Med 1982; 306: 969-72.
18. Segura A, Pardo J, Jara C, Zugazabeitia L,Carulla J, de las Peñas R, et al. Anepidemiological evaluation of the prevalence ofmalnutrition in Spanish patients with locallyadvanced or metastatic cancer. Clin Nutr 2005;24: 801-14.
19. Slaviero KA, Read JA, Clarke SJ, Rivory LP.Baseline nutritional assessment in advancedcancer patients receiving palliative chemotherapy.Nutr Cancer 2003; 46: 148-57.
20. Strasser F, Luftner D, Possinger K, Ernst G,Ruhstaller T, Meissner W, et al. Comparison oforally dministered cannabis extract and delta-9-tetrahydrocannabinol in treating patients withcancerrelated anorexia-cachexia syndrome: amulticenter, phase III, randomized, double-blind,placebocontrolled clinical trial from theCannabis-In-Cachexia-Study-Group. J Clin Oncol2006; 24: 3394-400.
21. Grimble R. Nutritional therapy for cancercachexia. Gut 2003; 52: 1391-2.
22. Rose DP, Connolly JM. Omega-3 fatty acids ascancer chemopreventive agents. Pharmacol Ther1999; 83: 217-44.
23. Argilés JM, Olivan M, Busquets S, LópezSoriano FJ. Optimal management of canceranorexia– cachexia syndrome. Cancer Manag Res2010; 2: 27-38.
24. Fearon K, Von Meyenfeldt M, Moses A, VanGeenen R, Roy A, Gouma D, et al. Effect of aprotein and energy dense N- ٣fatty acid enrichedoral supplement on loss of weight and lean tissuein cancer cachexia: a randomised double blindtrial. Gut 2003; 52: 1479-86.
25. Moses A, Slater C, Preston T, Barber M, FearonK. Reduced totals energy expenditure andphysical activity in cachectic patients withpancreatic cancer can be modulated by an energyand protein dense oral supplement enriched withn-3 fatty acids. Br J Cancer 2004; 90: 996-1002.
26. Giacosa A, Rondanelli M. Fish oil and treatmentof cancer cachexia. Genes Nutr 2008; 3: 25-8.
27. Kratz M, Callahan HS, Yang PY, Matthys CC,Weigle DS. Dietary n-3-polyunsaturated fattyacids and energy balance in overweight ormoderately obese men and women: a randomizedcontrolled trial. Nutr Metab (Lond) 2009; 6: 24.
28. Kapoor S. Immunomodulatory properties ofomega-3 fatty acids: a possible explanation fortheir systemic, anti-carcinogenic effects. J LeukocBiol 2009; 85: 2-3.
29. Goncalves CG, Ramos EJB, Romanova IV,Suzuki S, Chen C, Meguid MM. Omega-3 fattyacids improve appetite in cancer anorexia, buttumor resecting restores it. Surgery 2006; 139:202-8.
30. Barber MD. Cancer cachexia and its treatmentwith fish-oil-enriched nutritionalsupplementation.Nutrition 2001; 17: 751-5.
IssueVol 1, No 4 (Autumn 2015) QRcode
SectionOriginal Article(s)
Omega-3 Depression Anxiety Overweight Women

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Haghravan S, Keshavarz S, Sharafi S- elham, Alizadeh Z. Effect of Omega-3 PUFA as Supplementation with Lifestyle Modification on Depression and Anxiety in Overweight Women. J Nutr Sci & Diet. 2015;1(4):181-187.